Skip to content

Efficacy of Dexmedetomidine nasal spray on Perioperative Hemodynamics in Patients with Hypertension Undergoing Major Noncardiac Surgery

Efficacy of Dexmedetomidine nasal spray on Perioperative Hemodynamics in Patients with Hypertension Undergoing Major Noncardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086576
Enrollment
Unknown
Registered
2024-07-05
Start date
2024-07-05
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative Hemodynamics

Interventions

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. History of primary hypertension with blood pressure controlled within 160/90mmHg after standardized treatment; 2. ASA <= Class ?; cardiac function <= Class ?; 3. Plan to undergo major non-cardiac surgery, the expected operation time is at least 3 hours, and the expected hospital stay is at least 5 days; 4. BMI between 18-27.9 kg/m^2.

Exclusion criteria

Exclusion criteria: 1.Patients whose hypertension is not treated with regular medication; 2.Systolic blood pressure =180 and/or diastolic blood pressure =110mmHg on the first day before surgery; 3.Diagnosis of severe respiratory, cardiovascular, renal or hepatic dysfunction before surgery; 4.Allergies or contraindications to dexmedetomidine,benzodiazepines,opioids or their components; 5.Hemoglobin < 90 g/L; 6.Have a history of stroke or any other central nervous system disease within 6 months; 7.History of schizophrenia, epilepsy, Parkinson's disease, myasthenia gravis or other mental diseases; 8.History of alcoholism or psychotropic drug dependence; 9.Unable to communicate due to severe visual, hearing or language problems; 10.Severe sinus bradycardia or II-III degree atrioventricular block.

Design outcomes

Primary

MeasureTime frame
The area under the curve where the blood pressure was higher or lower than 20% of the basal blood pressure ;

Secondary

MeasureTime frame
Average real variability of systolic blood pressure;Sleep quality;Related inflammatory and stress biomarkers;Postoperative analgesia within 5 days;Postoperative recovery;Postoperative adverse reactions such as hypertension, hypotension, bradycardia, respiratory depression and dizziness within 48 hours after operation;

Countries

China

Contacts

Public ContactYan Tao

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences

blizzardyt@163.com+86 135 2255 3375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026